Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.44 |
| ▸ | PRKCG | P05129 | 1/20 | 0.44 |
| ▸ | PRKCB | P05771 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCH | P24723 | 1/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15870316 | 1.00 | PRKD3 (0.44) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL789290 | 1.00 | PRKD3 (0.44) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14968394 | 0.87 | CHRM2 (0.33) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL9958086 | 0.84 | CHRM2 (0.33) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL19696795 | 0.78 | CHRM2 (0.34) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL21771475 | 0.77 | CHRM2 (0.33) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL7762152 | 0.72 | PTPN1 (0.36) | APP | |
| SCHEMBL4965939 | 0.71 | TSHR (0.34) | KMT2A | |
| SCHEMBL789291 | 0.71 | METAP2 (0.30) | CHRM2CHRM1MEN1CYP2D6KMT2A | |
| SCHEMBL2479329 | 0.69 | FFAR3 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11154514-B2 | Quinic acid-modified nanoparticles and uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2021-10-26 | — | — | US | disclosed |
| US-20200060989-A1 | QUINIC ACID-MODIFIED NANOPARTICLES AND USES THEREOF | PURDUE RESEARCH FOUNDATION | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11154514-B2 | Quinic acid-modified nanoparticles and uses thereof | SELP, SELE, SELPLG | PRKD3 3998/4885PRKCG 2839/4885PRKCB 3092/4885 |
| US-20200060989-A1 | QUINIC ACID-MODIFIED NANOPARTICLES AND USES THEREOF | SELP, SELE, SELPLG | PRKD3 3998/4885PRKCG 2839/4885PRKCB 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.